Fei L. Kuang

Allergy and Immunology

675 N St Clair St Ste 18-250
Galter Pavilion
Chicago, IL 60611

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

The Secretome of Bullous Pemphigoid IgG-Treated Keratinocytes Induces a Pro-Inflammatory Eosinophil Response.

The Secretome of Bullous Pemphigoid IgG-Treated Keratinocytes Induces a Pro-Inflammatory Eosinophil Response.

Journal: Experimental dermatology

Published: February 02, 2026

Cellular profiling identifies targetable T cell phenotypes in lymphocytic variant hypereosinophilic syndrome.

Cellular profiling identifies targetable T cell phenotypes in lymphocytic variant hypereosinophilic syndrome.

Journal: The Journal of clinical investigation

Published: November 03, 2025

Circulating eosinophils in patients with hypereosinophilic syndrome have heterogeneous immunophenotypes.

Circulating eosinophils in patients with hypereosinophilic syndrome have heterogeneous immunophenotypes.

Journal: The journal of allergy and clinical immunology. Global

Published: September 05, 2025

Acid ceramidase regulates CD8+ T-cell exhaustion via type I interferon-mediated upregulation of PD-L1.

Acid ceramidase regulates CD8+ T-cell exhaustion via type I interferon-mediated upregulation of PD-L1.

Journal: Frontiers in immunology

Published: May 30, 2025

Type I IFN-dependent FcγRIV signaling in murine monocytes promotes lethal anaphylaxis during viral infections.

Type I IFN-dependent FcγRIV signaling in murine monocytes promotes lethal anaphylaxis during viral infections.

Journal: The Journal of clinical investigation

Published: February 24, 2025

Long-Term Efficacy and Safety of Benralizumab Treatment for PDGFRA-Negative Hypereosinophilic Syndrome.

Long-Term Efficacy and Safety of Benralizumab Treatment for PDGFRA-Negative Hypereosinophilic Syndrome.

Journal: The journal of allergy and clinical immunology. In practice

Published: October 11, 2024

Advancing toward a unified eosinophil signature from transcriptional profiling.

Advancing toward a unified eosinophil signature from transcriptional profiling.

Journal: Journal of leukocyte biology

Published: July 05, 2024

Eosinophilia and Adverse Effects of Dupilumab for Respiratory Indications: A Real-World Setting.

Eosinophilia and Adverse Effects of Dupilumab for Respiratory Indications: A Real-World Setting.

Journal: The journal of allergy and clinical immunology. In practice

Published: June 18, 2024

Advances and ongoing challenges in eosinophilic gastrointestinal disorders presented at the CEGIR/TIGERs Symposium at the 2024 American Academy of Allergy, Asthma & Immunology meeting.

Advances and ongoing challenges in eosinophilic gastrointestinal disorders presented at the CEGIR/TIGERs Symposium at the 2024 American Academy of Allergy, Asthma & Immunology meeting.

Journal: The Journal of allergy and clinical immunology

Published: June 09, 2024

Biologic therapy in rare eosinophil-associated disorders: remaining questions and translational research opportunities.

Biologic therapy in rare eosinophil-associated disorders: remaining questions and translational research opportunities.

Journal: Journal of leukocyte biology

Published: January 11, 2024

Little to no mRNA for the α- or β-chains of FcεRI in human eosinophils.

Little to no mRNA for the α- or β-chains of FcεRI in human eosinophils.

Journal: The Journal of allergy and clinical immunology

Published: September 13, 2023

A Cell-Free Protein Synthesis Platform to Produce a Clinically Relevant Allergen Panel.

A Cell-Free Protein Synthesis Platform to Produce a Clinically Relevant Allergen Panel.

Journal: ACS synthetic biology

Published: August 08, 2023

Showing 1-12 of 31

Last Updated: 09/26/2026